Tuesday, May 11, 2021

Covaxin Recommended For Next Phase Of Trials For 2-18 Age Group: Report

Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase-2 and phase-3 clinical trials on those aged between two to 18 years, official sources said.

No comments:

Post a Comment

Indian Techie Claims Boss Made Work Life A "Mess" For Rejecting His Proposal

An Indian tech professional has alleged that her European manager, who is married, began targeting her professionally after she rejected his...